Lv1
8 积分 2023-03-06 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Natural Products in Liver Fibrosis Management: A Five-year Review
1个月前
已完结
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
1个月前
已完结
Mitochondrial Proteomics Uncovers that Myeloid S100A9 Deficiency Promotes Liver Injury and Fibrosis Regression via Mitochondrial Metabolic Reprogramming of Macrophages
2个月前
已完结
Effector T Cell Analysis of Melanoma Tumor-infiltrating Lymphocyte Cultures Using HLA-ABC Semimatched Melanoma Cell Lines
6个月前
已完结
Deep-Coverage Ubiquitylomics with Low Starting Materials Reveals Dysregulation of Ubiquitinated FASN as a Key Regulator of MAFLD Pathogenesis
7个月前
已完结
Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
1年前
已完结
皖公网安备34019202002308
